Attovia Therapeutics, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Attovia Therapeutics, Inc. (ATTO) had Common Stock, Capital Shares Reserved for Future Issuance of 24.59 million shares as of 2026-06-30, per its 10-Q filed 2026-09-02.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-09-02
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 24.59M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 24.61M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 24.59M shares 10-Q · filed 2026-09-02 |
| 2025-12-31 | 24.61M shares 10-Q · filed 2026-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |